Abstract
As part of the spectrum of renal replacement therapies, kidney transplantation has been successful in providing the end-stage renal disease patient with a long-term, medically sound, and economically advantageous alternative to chronic dialysis. 1 The applicability of its success, however, has been limited by the ever-widening disparity between the steadily increasing number of eligible candidates and the relatively fixed number of available donors per year. This trend was partially offset in 2001, when the number of living kidney donors surpassed that of cadaveric donors. 2 In an effort to increase the availability of live donors, new techniques focused on facilitating the donation process through the use of laparoscopy. Adjunctive efforts were also directed toward overcoming previous immunologic barriers between donors and recipients, such as transplantation across “ABO incompatible” pairs. Renal insufficiency and an allocation policy change in the livertransplant recipient impact the supply of cadaveric donor kidneys and directly affect the renal healthcare worker; the perioperative management of these patients is discussed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call